AU736347B2 - Compounds for and a method of inhibiting matrix metalloproteinases - Google Patents
Compounds for and a method of inhibiting matrix metalloproteinases Download PDFInfo
- Publication number
- AU736347B2 AU736347B2 AU41770/97A AU4177097A AU736347B2 AU 736347 B2 AU736347 B2 AU 736347B2 AU 41770/97 A AU41770/97 A AU 41770/97A AU 4177097 A AU4177097 A AU 4177097A AU 736347 B2 AU736347 B2 AU 736347B2
- Authority
- AU
- Australia
- Prior art keywords
- sulfonylamino
- dibenzofuran
- acid
- hexanoic acid
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/76—Dibenzothiophenes
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Lubricants (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2506396P | 1996-09-04 | 1996-09-04 | |
| US60/025063 | 1996-09-04 | ||
| US5571497P | 1997-08-07 | 1997-08-07 | |
| US60/055714 | 1997-08-07 | ||
| PCT/US1997/015444 WO1998009957A1 (en) | 1996-09-04 | 1997-09-02 | Compounds for and a method of inhibiting matrix metalloproteinases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU4177097A AU4177097A (en) | 1998-03-26 |
| AU736347B2 true AU736347B2 (en) | 2001-07-26 |
Family
ID=26699217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU41770/97A Ceased AU736347B2 (en) | 1996-09-04 | 1997-09-02 | Compounds for and a method of inhibiting matrix metalloproteinases |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6294674B1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP0929542A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2002514180A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20000068415A (cg-RX-API-DMAC10.html) |
| AU (1) | AU736347B2 (cg-RX-API-DMAC10.html) |
| BR (1) | BR9712794A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2256631A1 (cg-RX-API-DMAC10.html) |
| HR (1) | HRP970474B1 (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ333064A (cg-RX-API-DMAC10.html) |
| WO (1) | WO1998009957A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6919375B1 (en) | 1996-01-23 | 2005-07-19 | Shionogi & Co., Ltd. | Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| NZ325939A (en) * | 1996-01-23 | 2000-06-23 | Shionogi & Co | Sulphonated amino acid derivatives and matrix metalloproteinase inhibitors (MMP) containing these derivatives |
| MXPA99001974A (es) * | 1996-12-09 | 2002-03-27 | Warner Lambert Co | Metodo para tratar y prevenir fallas cardiacas y dilatacion ventricular. |
| OA11589A (en) | 1998-07-30 | 2004-07-30 | Warner Lambert Co | Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases. |
| US6350885B1 (en) | 1998-07-30 | 2002-02-26 | Warner-Lambert Company | Tricyclic heteroaromatics and their derivatives as inhibitors of matrix metalloproteinases |
| WO2000015213A1 (en) * | 1998-09-11 | 2000-03-23 | Shionogi & Co., Ltd. | Remedal or preventive agent for congestive heart failure |
| CN1229339C (zh) * | 2000-03-27 | 2005-11-30 | 斯克里普斯研究学院 | 抑制血管生成和肿瘤生长的化合物,含有该化合物的药用制剂,以及该化合物的制药用途 |
| GB2365425A (en) * | 2000-08-01 | 2002-02-20 | Parke Davis & Co Ltd | Alkyl amino acid derivatives useful as pharmaceutical agents |
| US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US7232924B2 (en) | 2001-06-11 | 2007-06-19 | Xenoport, Inc. | Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US20030129672A1 (en) * | 2001-08-29 | 2003-07-10 | Dyer Richard Dennis | Method for identifying metalloenzyme inhibitors |
| PE20030701A1 (es) | 2001-12-20 | 2003-08-21 | Schering Corp | Compuestos para el tratamiento de trastornos inflamatorios |
| WO2004060346A2 (en) | 2002-12-30 | 2004-07-22 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
| CN1318411C (zh) * | 2005-03-21 | 2007-05-30 | 中国海洋大学 | 氢化轮枝霉酮类化合物及其制备方法和用途 |
| AU2006332694A1 (en) * | 2005-12-30 | 2007-07-12 | Alantos Pharmaceuticals, Holding, Inc. | Substituted bis-amide metalloprotease inhibitors |
| EP2074107A2 (en) * | 2006-10-27 | 2009-07-01 | Wyeth a Corporation of the State of Delaware | Tricyclic compounds as matrix metalloproteinase inhibitors |
| GB0621973D0 (en) * | 2006-11-03 | 2006-12-13 | Philogen Spa | Binding molecules and uses thereof |
| AR066412A1 (es) * | 2007-05-04 | 2009-08-19 | Wyeth Corp | Derivados de dibenzofurano y dibenzotiofeno, composiciones farmaceuticas que los contienen y usos en patologias tales como trastornos oseos, crecimiento de tumores, diabetes y obesidad. |
| CA2692004C (en) * | 2007-06-15 | 2013-04-09 | Board Of Regents, The University Of Texas System | Methods and compositions to inhibit edema factor and adenylyl cyclase |
| JP2012051804A (ja) * | 2008-12-26 | 2012-03-15 | Kyoto Univ | Eg5阻害剤 |
| TWI747873B (zh) * | 2016-02-01 | 2021-12-01 | 美商百歐克斯製藥公司 | 苯并吡唑化合物及其類似物 |
| WO2021147882A1 (zh) * | 2020-01-21 | 2021-07-29 | 深圳信立泰药业股份有限公司 | 一种二苯并呋喃类衍生物组织蛋白酶k抑制剂及其制备方法和医药用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2065966C3 (de) | 1969-09-06 | 1978-11-16 | Ajinomoto Co., Inc., Tokio | N-Fluorenyl-sulfonyl-aminocarbonsäuren sowie diese enthaltende Mittel |
| US3845097A (en) | 1969-09-06 | 1974-10-29 | Ajinomoto Kk | N-substituted amino acids and novel ester |
| US4097472A (en) | 1974-11-08 | 1978-06-27 | Mitsubishi Chemical Industries Limited | N2 -arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof |
| DE2236876C3 (de) * | 1971-08-19 | 1981-02-12 | Ajinomoto Co., Inc., Tokio | N-Substituierte Aminocarbonsäuren und diese Verbindungen enthaltende Arzneimittel |
| EP0183271B1 (en) * | 1984-11-30 | 1990-05-16 | Shosuke Okamoto | Lysin derivative and proteinase inhibitor |
| PH31294A (en) * | 1992-02-13 | 1998-07-06 | Thomae Gmbh Dr K | Benzimidazolyl derivatives, pharmaceutical compositions containing these compounds and process for preparing them. |
| US5455258A (en) | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
| US5627206A (en) | 1995-06-02 | 1997-05-06 | Warner-Lambert Company | Tricyclic inhibitor of matrix metalloproteinases |
| US5665764A (en) | 1995-06-02 | 1997-09-09 | Warner-Lambert Company | Tricyclic inhibitors of matrix metalloproteinases |
| DK0828726T3 (da) | 1995-06-02 | 2002-01-21 | Warner Lambert Co | Tricykliske inhibitorer af matrixmetalloproteinaser |
| SK282833B6 (sk) | 1995-11-17 | 2002-12-03 | Warner-Lambert Company | Sulfónamidové inhibítory matricových metaloproteináz a farmaceutická kompozícia obsahujúca tieto inhibítory |
| NZ325939A (en) | 1996-01-23 | 2000-06-23 | Shionogi & Co | Sulphonated amino acid derivatives and matrix metalloproteinase inhibitors (MMP) containing these derivatives |
| NZ333063A (en) | 1996-09-04 | 2000-12-22 | Warner Lambert Co | Dibenzofuran sulfonamide derivatives as matrix metalloproteinase inhibitors |
-
1997
- 1997-09-02 KR KR1019997001757A patent/KR20000068415A/ko not_active Abandoned
- 1997-09-02 JP JP51281898A patent/JP2002514180A/ja not_active Abandoned
- 1997-09-02 CA CA002256631A patent/CA2256631A1/en not_active Abandoned
- 1997-09-02 EP EP97939751A patent/EP0929542A1/en not_active Withdrawn
- 1997-09-02 NZ NZ333064A patent/NZ333064A/xx unknown
- 1997-09-02 WO PCT/US1997/015444 patent/WO1998009957A1/en not_active Ceased
- 1997-09-02 AU AU41770/97A patent/AU736347B2/en not_active Ceased
- 1997-09-02 US US09/254,403 patent/US6294674B1/en not_active Expired - Fee Related
- 1997-09-02 BR BR9712794-9A patent/BR9712794A/pt not_active Application Discontinuation
- 1997-09-04 HR HR970474A patent/HRP970474B1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US6294674B1 (en) | 2001-09-25 |
| WO1998009957A1 (en) | 1998-03-12 |
| EP0929542A1 (en) | 1999-07-21 |
| KR20000068415A (ko) | 2000-11-25 |
| BR9712794A (pt) | 1999-12-14 |
| CA2256631A1 (en) | 1998-03-12 |
| JP2002514180A (ja) | 2002-05-14 |
| HRP970474A2 (en) | 1998-12-31 |
| HRP970474B1 (en) | 2002-10-31 |
| NZ333064A (en) | 2000-11-24 |
| AU4177097A (en) | 1998-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6294674B1 (en) | Dibenzofuran sulfonamide matrix metalloproteinase inhibitors | |
| US6117869A (en) | Compounds for and methods of inhibiting matrix metalloproteinases | |
| AU735013B2 (en) | Matrix metalloproteinase inhibitors and their therapeutic uses | |
| KR100352316B1 (ko) | 메탈로프로테아제억제제로서사용되는술포닐아미노치환히드록삼산유도체 | |
| EP0960108B1 (en) | Matrix metalloproteinase inhibitors | |
| US5387610A (en) | Peptide derivatives of collagenase inhibitor | |
| KR20000035917A (ko) | 1,4-헤테로고리성 메탈로프로테아제 저해제 | |
| NZ321293A (en) | Sulfonamide inhibitors of matrix metalloproteinases | |
| JP2014111615A (ja) | ヒストンデアセチラーゼの阻害薬及びそのプロドラッグ | |
| CZ195298A3 (cs) | Aromatické keto-kyseliny a jejich deriváty jako inhibitory matricových metaloproteináz | |
| EP1210326B1 (en) | Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors | |
| WO1991009851A1 (fr) | Derive d'oxyde de 1,3,2-dioxathiolane | |
| JPWO2009001730A1 (ja) | βセクレターゼ阻害活性を有する新規化合物 | |
| US6620835B2 (en) | Method of inhibiting matrix metalloproteinases | |
| KR20020038951A (ko) | 베타 이치환된 메탈로프로테아제 저해제 | |
| MXPA98009929A (en) | Compounds for and a method of inhibiting matrix metalloproteinases | |
| US6420341B1 (en) | Sulphur derivatives with a retroamide bond as endothelin-converting enzyme inhibitors | |
| CA2233560C (en) | Sulfonamide inhibitors of matrix metalloproteinases | |
| MXPA98009871A (en) | Matrix metalloproteinase inhibitors and their therapeutic uses | |
| CZ2001302A3 (cs) | Tricyklické sulfonamidy a jejich deriváty jako inhibitory matricových metaloproteináz | |
| HK1033666A1 (en) | Matrix metalloproteinase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |